Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Walgreens reviving talks to offload £7 billion UK Boots pharmacy chain

Walgreens reviving talks to offload £7 billion UK Boots pharmacy chain
Photo: iStock

The company earlier scrapped its plans to sell the UK high street pharmacy chain after failing to secure the desired valuation for the business

Walgreens Boots Alliance is in discussions about ways to separate its UK-based Boots drugstore chain, and it is considering the possibility of an initial public offering (IPO) in London, Bloomberg News reported on Tuesday.


People familiar with the matter told the publication that the drugstore chain could be valued at about £7 billion ($8.8 billion) in a deal, but the sale process could only start next year at the earliest.

The US company invited bids for Boots last year but scrapped the plan in June 2022 after failing to secure the desired valuation for the business due to a turbulent credit market.

As per the report, Walgreens may invite fresh offers for the UK high street pharmacy chain, but deliberations are still at a preliminary stage and it’s not certain they will lead to a transaction.

Until 2022, Boots has a network of more than 2,000 stores across the UK and Ireland including local pharmacies and large health and beauty shops, and employs over 52,000 people.

Earlier this year, the company announced plans to shut down 300 stores in the country in the next 12 months, mostly those in close proximity to other outlets, in a bid to increase ‘efficiency’.

The high street retailer has already shut a number of stores this year including its branches in Mudge Way, Plymouth; Mount Pleasant Road, Exeter;  Low Moor Road, Kirkby, Ashfield; and Gorleston High Street, Great Yarmouth.

Boots stores that would be shut down in the near future include Cambridge Road, Stanstead (January 6); Northdown Road, Margate, Kent (January 20); Wood Street, Swindon (February 9); and Front Street, Prudhoe (TBC).

Walgreens reached a deal in November to transfer its £4.8 billion ($6 billion) pension plan to financial services company Legal & General Group Plc.

The pension scheme is seen as a stumbling block that had complicated previous efforts to sale the business.

More For You

A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less
Patients to get test results via NHS app

An investment of £50m has been made to upgrade the NHS app

Patients to get test results via NHS app

Millions of patients will now be able to access test results and get appointment reminders on their smartphones as the government tries to position the NHS app as the default mode of communication and steer away from traditional methods like letters.

An investment of £50m has been made to upgrade the NHS app and the health service hopes to save £200m over the next three years.

Keep ReadingShow less
Health minister assures House of Lords on measures to tackle UK-wide Creon drug shortage

Baroness Merron

Government taking steps to mitigate shortage of cancer drug Creon

Baroness Merron on Monday (9) assured the House of Lords that the government is taking measures to mitigate the shortage of pancreatic cancer drug Creon across the country.

Raising the issue, Baroness Margaret Ritchie wanted to know about the steps being taken by the government to ease the misery of patients suffering from pancreatic cancer.

Keep ReadingShow less
Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Janet Morrison

Janet Morrison: "Eventual outcome of spending review needs to tackle pharmacy underfunding"

Community Pharmacy England (CPE) chief executive Janet Morrison has welcomed chancellor Rachel Reeves announcement today that day-to-day spending on the NHS will increase by £29bn a year but insisted that it must reflect in securing the future of pharmacy.

Reeves also revealed that the government will be increasing the NHS technology budget by almost 50 per cent, with £10bn of investment to "bring our analogue health system into the digital age, including through the NHS app".

Keep ReadingShow less
Lynsey Cleland named GPhC chief standards officer

Lynsey Cleland

Pic credit: X

Lynsey Cleland named GPhC chief standards officer

The General Pharmaceutical Council (GPhC) has brought back Lynsey Cleland to lead on a number of important departments in the role of chief standards officer.

Cleland had previously held a number of senior positions at GPhC, including director of Scotland.

Keep ReadingShow less